NEVVI Medicare utilization intelligence
or

← back

Provider profile

MCCOLLUM MILLER, EMILY M.D.

Hematology-Oncology · NPI 1407236144 · ASHEVILLE, NC

1
Groups
53
Codes · 2024
38,686
Disclosed services

MCCOLLUM MILLER, EMILY is a Hematology-Oncology in ASHEVILLE, NC, a member of 1 medical group, who billed 53 distinct codes to Medicare Part B in 2024.

Groups: AMERICAN ONCOLOGY PARTNERS PA (FORT WAYNE, IN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒

Provider overview · all codes · CY2024

38,686
disclosed services
53
codes billed to Medicare Part B
Prior year · CY2023 45,303 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9299 Injection, nivolumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1930 Injection, lanreotide, 1 mg
J0897 Injection, denosumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J9041 Injection, bortezomib, 0.1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
36415 Insertion of needle into vein for collection of blood sample
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J9395 Injection, fulvestrant, 25 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
J2405 Injection, ondansetron hydrochloride, per 1 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
J3489 Injection, zoledronic acid, 1 mg
J9045 Injection, carboplatin, 50 mg
96372 Injection of drug or substance under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J1200 Injection, diphenhydramine hcl, up to 50 mg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96361 Infusion into a vein for hydration, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
81002 Urinalysis, manual test
96415 Administration of chemotherapy into vein, each additional hour
96523 Irrigation of implanted venous access drug delivery device
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J3490 Unclassified drugs
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
96374 Injection of drug or substance into vein
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
78816 Nuclear medicine study whole body with ct scan
96411 Administration of additional new drug or substance into vein using push technique
99195 Drawing of blood for a medical problem

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.